# US 2022/0016315 A1 · Biodegradeable implant comprising coated metal alloy product

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0016315 A1
- Document ID: US20220016315A1
- Status: Published application
- Kind: A1
- Application number: 17/296,244
- Filed: 2019-11-22
- Published: 2022-01-20
- Earliest claimed: 2018-11-23
- Assignees: Meotec GmbH & Co. KG
- Applicants: Meotec GmbH
- Inventors: Alexander Kopp
- Web page: https://patentgrep.com/patent/US20220016315A1

## CPC

- A61L 27/047: {Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06}
- A61L 27/32: Phosphorus-containing materials, e.g. apatite
- A61L 27/306: {Other specific inorganic materials not covered by A61L27/303 - A61L27/32}
- A61L 27/58: Materials at least partially resorbable by the body
- A61L 31/028: {Other inorganic materials not covered by A61L31/022 - A61L31/026}
- A61L 31/086: {Phosphorus-containing materials, e.g. apatite}
- A61L 31/088: {Other specific inorganic materials not covered by A61L31/084 or A61L31/086}
- A61L 31/148: {Materials at least partially resorbable by the body}
- C22C 18/00: Alloys based on zinc
- C22C 23/00: Alloys based on magnesium
- C25D 11/024: {Anodisation under pulsed or modulated current or potential}
- C25D 11/026: {Anodisation with spark discharge}
- C25D 11/30: of magnesium or alloys based thereon
- C25D 11/36: Phosphatising
- A61L 2420/02: Methods for coating medical devices
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C22C: ALLOYS (treatment of alloys C21D, C22F)
- C25D: PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR

## Abstract

The invention relates to a biodegradable implant comprising a surface coated magnesium alloy or zinc alloy product, whereby the coating layer comprises oxides and/or phosphates of from rare-earth elements, Mg, Ca, Zn, Zr, Cu, Fe, Sr, Li, Mn or Ag wherein the coating is preferably generated by plasma electrolytically oxidation (PEO). The invention further comprises a method for preparing the coated magnesium or zinc alloy product of the implant.

## Claims

### Claim at position 1

1-13. (canceled)

### Claim 14

Biodegradable implant comprising a magnesium or zinc alloy productcoated on its surface with a coating layer comprising at least three substances being
a. a metal oxide of a metal selected from rare-earth elements, Mg, Ca, Zn, Zr, Cu, Sr, Li, Mn or Ag; and/or
b. a metal phosphate of a metal selected from rare-earth elements, Mg,Ca, Zn, Zr, Cu, Sr, Li, Mn or Ag.

### Claim 15 (depends on 14)

Biodegradable implant according to claim 14, wherein the coated magnesiumor zinc alloy product comprises the following characteristic: the metal oxide or metal phosphate forms an amorphous domain within the coating layer.

### Claim 16 (depends on 14)

Biodegradable implant according to claim 14, wherein the metal oxide ormetal phosphate of the coated magnesium or zinc alloy product forms a crystalline domain within the coating layer.

### Claim 17 (depends on 14)

Biodegradable implant according to claim 14, wherein the coated
magnesium or zinc alloy product comprises the following characteristic: the coating layer has a thickness of between 2 to 50 μm, preferably 5 to 35 μm, particularly preferably of between 8 to 24 μm and especially of between 12 to 18 μm.

### Claim 18 (depends on 14)

Biodegradable implant according to claim 14, wherein the coated magnesium or zinc alloy product comprises the following characteristic: the coating layer comprises metal fluorides which increase in their concentration starting from the top surface of the coating layer down to the bottom, alloy-product oriented surface of the coating layer, building preferably a distinct metal fluoride enriched zone at the bottom surface ofthe coating layer.

### Claim 19 (depends on 14)

Biodegradable implant according to claim 14, wherein the coated magnesium or zinc alloy product comprises the following characteristic: the top surface of the coating layer has a mean Vickers hardness from 150 to800, preferably from 200 to 600, and more preferably from 250 to 400, asmeasured according DIN EN ISO 6507-1/4:2018.

### Claim 20 (depends on 14)

Biodegradable implant according to claim 14, wherein the coated magnesium or zinc alloy product comprises the following characteristic: thecoating layer comprises at least two sub layers being a bottom, alloy-product oriented barrier layer and a porous top layer.

### Claim 21 (depends on 14)

Biodegradable implant according to claim 14, wherein the coated magnesium or zinc alloy product comprises the following characteristic: thecoating layer is generated by plasma electrolytically oxidation (PEO).

### Claim 22 (depends on 14)

Biodegradable implant according to claim 14, wherein the coating layer is manufactured by a conversion coating, preferably an anodizing treatment,more preferably a PEO.

### Claim 23 (depends on 14)

Biodegradable implant according to claim 14, wherein the coating layeris a porous layer, which preferably has a porosity of 2 to 50%, more preferably of between 3 to 25%, and particularly preferable of 4 to 12%.

### Claim 24 (depends on 23)

Biodegradable implant according to claim 23, wherein the pores of at thetop surface of the coating layer have a mean pore size of between 0.1 to 10, preferably of 2 to 8, particularly preferably of 4 to 6 μm2.

### Claim 25 (depends on 14)

Biodegradable implant according to claim 14, wherein the magnesium alloy is selected from the group consisting of a Magnesium silver alloy (Mg—Ag), a Mg alloy containing rare elements (RE), preferably a Mg—Y-RE alloy and more preferably a Mg—Y—Nd with or without addition of Zr, even more preferred with a Y content between 3 and 5% wt.-% and a Nd content between 2 and 4% wt.-%; or a Mg alloy comprising Calcium and Zink, preferably Mg—Ca—Zn or Mg—Zn—Ca with or without addition of Zr,even more preferably with Ca and Zn contents each below 1 wt.-%.

### Claim 26 (depends on 14)

Biodegradable implant according to claim 14, wherein the zinc alloy is selected from the group consisting of a zinc-magnesium alloy (Zn—Mg) with or without the addition of calcium (Zn—Ca—Mg or Zn—Mg—Ca), azinc-silver alloy (Zn—Ag) with or without the addition of magnesium (Zn—Ag—Mg or Zn—Mg—Ag), a zinc-strontium alloy (Zn—Sr) with or without the additionof magnesium (Zn—Sr—Mg or Zn—Mg—Sr), a zinc-lithium alloy (Zn—Li) with or without the addition of magnesium (Zn—Li—Mg or Zn—Mg—Li), a zinc-calcium alloy (Zn—Ca) with or without the addition of magnesium (Zn—Ca—Mg or Zn—Mg—Ca) or a zinc-manganese alloy (Zn—Mn) with or without the addition of magnesium (Zn—Mn—Mg or Zn—Mg—Mn).

### Claim 27 (depends on 14)

Biodegradable implant according to claim 14, wherein implantis manufactured by conventional (subtractive) or additive manufacturingmethods.

### Claim 28 (depends on 14)

Biodegradable implant according to claim 14, wherein the implant comprises at least 2 or more sublayers, which can be separated by analytical measurements of the phase composition, crystalline content or visible features.

### Claim 29 (depends on 14)

Biodegradable implant according to claim 14, wherein the coated magnesium or zinc alloy product after incubation for 100 hours in Minimal Essential Medium (MEM) at 37° C. under non-turbulent stirring has ahydrogen gas evolution rate of less than 1.0 ml/cm2, preferably of less than 0.6 ml/cm2, more preferably of less than 0.2 ml/cm2, and even more preferably of less than 0.1 ml/cm2, as measured by continuous volumetricmeasurement of the generated hydrogen gas.

### Claim 30 (depends on 26)

Method for generating a coating layer on the surface of a magnesium or zinc alloy product, preferably of a magnesium alloy product according to claim 26, comprising the following steps:
Providing an aqueous electrolyte solution comprising an inorganicphosphate,
(ii) subjecting a magnesium alloy or zinc alloy product to the aqueouselectrolyte solution so that the surface of the magnesium alloy product or the zinc alloy product which is to be treated is immersed in the electrolyte solution,
(iii) applying an voltage difference between the magnesium or zinc alloy product and a second electrode positioned in the aqueous electrolyte system for generating a plasma electrolytic oxidation onthe immersed surface of the magnesium alloy product or the zinc alloy product,
(iv) so that the immersed surface is converted to a mixedoxide/phosphate film.

### Claim 31 (depends on 30)

Method for treating a surface of magnesium or zinc alloy product according to claim 30, wherein the aqueous electrolyte solution has one or more of the following characteristics:
a. The aqueous electrolyte solution comprises an inorganic phosphate which is preferably selected from the list consisting of phosphoric acid, Na3PO4, Na4P2O7, Na5P3O10, Na6P6O18, Na2HPO4, NaH2PO4, and K2P2O7;
b. The aqueous electrolyte solution comprises an inorganic phosphatein a concentration of between 1 and 250 g/L.

### Claim 32 (depends on 31)

Method for treating a surface of magnesium or zinc alloy product according to claim 31, wherein the aqueous electrolyte solution comprises in addition
to an inorganic phosphate one or more alkaline compounds, preferably selected from the list consisting of ammonium hydroxide, sodium hydroxide,potassium hydroxide and lithium hydroxide.

### Claim 33 (depends on 31)

Method for treating a surface of magnesium or zinc alloy product according to claim 31, wherein the aqueous electrolyte solution further comprises one or more additives selected from hydrogen fluoride, urotropinand boric acid.

### Claim 34 (depends on 31)

Method for treating a surface of magnesium or zinc alloy product according to claim 31, wherein the voltage and/or current as applied in step (iii) is unipolar or bipolar pulsed with a pulse frequency which is preferably between 1 and 5 kHz, more preferably between 10 and 1.500 Hz and most preferably between 50 and 500 or between 100 and 1.000 Hz.
